216 studies found for:    Open Studies | "Psoriasis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Psoriasis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting MSB11022 in Moderate to Severe Chronic Plaque Psoriasis
Conditions: Psoriasis;   Plaque Type Psoriasis;   Moderate to Severe Plaque Psoriasis
Interventions: Drug: MSB11022;   Drug: Humira®
2 Unknown  Determination of Lymphocyte JAM-C Expression in Patients With Psoriasis Vulgaris
Conditions: Psoriasis;   Psoriasis Vulgaris
Intervention:
3 Recruiting Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis
Conditions: Plaque Psoriasis;   Psoriasis
Interventions: Biological: etanercept;   Biological: etanercept (half dose);   Drug: placebo
4 Recruiting Evaluation of Adipokines and Fat Tissue in Psoriasis and Psoriatic Arthritis
Conditions: Psoriasis;   Arthritic Psoriasis
Interventions: Other: bone densitometry;   Other: questionnaires;   Other: biological analyses
5 Recruiting A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis
Conditions: Genital Psoriasis;   Psoriasis
Interventions: Drug: Ixekizumab;   Drug: Placebo
6 Recruiting A Registry of Patients With Moderate to Severe Plaque Psoriasis
Condition: Psoriasis
Intervention:
7 Unknown  A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis
Conditions: Scalp Psoriasis;   Plaque Psoriasis
Interventions: Drug: Ustekinumab;   Drug: Placebo
8 Recruiting Diabetes and Psoriasis
Conditions: Diabetes;   Psoriasis
Intervention: Other: PASI and HOMA index
9 Recruiting A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis
Condition: Psoriasis
Intervention: Drug: Apremilast
10 Unknown  miRNAs and mRNAs in Psoriasis
Condition: Psoriasis
Intervention: Other: 4 mm punch biopsies
11 Unknown  Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis
Conditions: Tuberculosis;   Psoriasis
Intervention: Other: Tuberculin skin test and Quantiferon -TB Gold test
12 Not yet recruiting The Association Between Psoriasis and Intestinal Bacterial Population
Condition: Psoriasis
Intervention:
13 Recruiting Spanish Registry of Systemic Treatments in Psoriasis
Condition: Psoriasis
Intervention:
14 Recruiting Excimer Laser, Serum Markers & Psoriasis
Condition: Psoriasis
Intervention: Device: Excimer laser treatment
15 Not yet recruiting Cutaneous Microcirculation and Nervous Sensitivity in Psoriasis
Condition: Psoriasis
Interventions: Other: Acetylcholine iontophoresis;   Other: Sodium Nitroprussiate iontophoresis;   Other: ppi water iontophoresis;   Other: Laser Doppler recording
16 Recruiting PsoBest - The German Psoriasis Registry
Conditions: Psoriasis;   Psoriatic-arthritis
Intervention:
17 Recruiting Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U)
Conditions: Psoriasis;   Cardiovascular Disease
Interventions: Drug: Ustekinumab;   Drug: Placebo
18 Recruiting The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis
Condition: Psoriasis
Interventions: Drug: Riboflavin;   Other: Placebo
19 Recruiting Serum, Cellular and Imaging Markers of Arthritis in Psoriasis Patients
Condition: Psoriasis
Intervention:
20 Unknown  TNF-alfa Inhibitors and Antibody Production in Patients With Psoriasis
Condition: Psoriasis
Intervention: Drug: subjects will receive either infliximab, adalimumab or etanercept

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years